Ionis Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Ionis Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ionis Pharmaceuticals Inc Strategy Report
- Understand Ionis Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Ionis Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 09 Dec 2020 | Akcea Therapeutics Expands Distribution Agreement with Swedish Orphan Biovitrum (Sobi) | Partnership | - |
Swedish Orphan Biovitrum AB
Akcea Therapeutics Inc
|
| 31 Aug 2020 | Ionis Pharma Acquires Remaining 24% Stake in Akcea Therapeutics | Acquisition |
Ionis Pharmaceuticals Inc
|
Akcea Therapeutics Inc
|
| 18 Dec 2019 | Akcea Therapeutics and Ionis Pharma Retains Rights to AKCEA-APOCIII-LRx from Novartis | Licensing Agreement |
Ionis Pharmaceuticals Inc
Akcea Therapeutics Inc
|
Novartis AG |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer